Stay updated on Efficacy Safety in Primary IgA Nephropathy Clinical Trial

Sign up to get notified when there's something new on the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now displayed on the page, replacing the previous v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-15T03:06:57.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    A new Locations section has been added and California is now listed under locations, replacing the previous California Locations grouping. The HHS Vulnerability Disclosure footer link has been removed and the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-17T19:43:38.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.2.0 in the page footer. There are no changes to the study data or visible content.
    Difference
    0.1%
    Check dated 2025-11-26T08:20:41.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Removed the site-wide banner about government funding lapses and NIH operating status; core study details and content remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-19T08:39:17.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-10-28T05:11:26.000Z thumbnail image
  8. Check
    109 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and operating-status guidance, and confirmed the NIH Clinical Center is open with sources. - Version updated from v3.1.0 to v3.2.0.
    Difference
    4%
    Check dated 2025-10-06T15:54:43.000Z thumbnail image

Stay in the know with updates to Efficacy Safety in Primary IgA Nephropathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page.